Cargando…
Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399048/ https://www.ncbi.nlm.nih.gov/pubmed/32850920 http://dx.doi.org/10.3389/fmed.2020.00453 |
| _version_ | 1783566071652941824 |
|---|---|
| author | Cadegiani, Flavio A. Wambier, Carlos G. Goren, Andy |
| author_facet | Cadegiani, Flavio A. Wambier, Carlos G. Goren, Andy |
| author_sort | Cadegiani, Flavio A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7399048 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73990482020-08-25 Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Cadegiani, Flavio A. Wambier, Carlos G. Goren, Andy Front Med (Lausanne) Medicine Frontiers Media S.A. 2020-07-28 /pmc/articles/PMC7399048/ /pubmed/32850920 http://dx.doi.org/10.3389/fmed.2020.00453 Text en Copyright © 2020 Cadegiani, Wambier and Goren. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Medicine Cadegiani, Flavio A. Wambier, Carlos G. Goren, Andy Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19 |
| title | Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19 |
| title_full | Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19 |
| title_fullStr | Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19 |
| title_full_unstemmed | Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19 |
| title_short | Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19 |
| title_sort | spironolactone: an anti-androgenic and anti-hypertensive drug that may provide protection against the novel coronavirus (sars-cov-2) induced acute respiratory distress syndrome (ards) in covid-19 |
| topic | Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399048/ https://www.ncbi.nlm.nih.gov/pubmed/32850920 http://dx.doi.org/10.3389/fmed.2020.00453 |
| work_keys_str_mv | AT cadegianiflavioa spironolactoneanantiandrogenicandantihypertensivedrugthatmayprovideprotectionagainstthenovelcoronavirussarscov2inducedacuterespiratorydistresssyndromeardsincovid19 AT wambiercarlosg spironolactoneanantiandrogenicandantihypertensivedrugthatmayprovideprotectionagainstthenovelcoronavirussarscov2inducedacuterespiratorydistresssyndromeardsincovid19 AT gorenandy spironolactoneanantiandrogenicandantihypertensivedrugthatmayprovideprotectionagainstthenovelcoronavirussarscov2inducedacuterespiratorydistresssyndromeardsincovid19 |